Lexicon Pharmaceuticals Inc (LXRX)

Apr 05, 2026

Lexicon Pharmaceuticals (LXRX) price target increased by 15.07% to 3.43 - MSN

Apr 05, 2026

Apr 04, 2026

Lexicon Pharmaceuticals, Inc. (LX31.MU) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026

Apr 02, 2026

Lexicon Pharmaceuticals joins Texas Life Sciences Summit to engage industry leaders and drive sector momentum - Traders Union

Apr 02, 2026

Apr 02, 2026

LXRX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 01, 2026

LXRX SEC FilingsLexicon Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - stocktitan.net

Apr 01, 2026

Apr 01, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8.7% HigherTime to Buy? - MarketBeat

Apr 01, 2026

Apr 01, 2026

LXRX stock up as NVO initiates phase I study of partnered obesity drug - MSN

Apr 01, 2026

Mar 31, 2026

Certain Stock Options of Lexicon Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 1-APR-2026. - marketscreener.com

Mar 31, 2026

Mar 31, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Passes Above Two Hundred Day Moving AverageHere's Why - marketbeat.com

Mar 31, 2026

Mar 30, 2026

Lexicon Pharmaceuticals unveils ACC26 trial analysis on BMI and cardiovascular outcomes - Traders Union

Mar 30, 2026

Mar 29, 2026

Published on: 2026-03-29 16:03:42 - baoquankhu1.vn

Mar 29, 2026

Mar 28, 2026

Lexicon Pharmaceuticals unveils new SOTA‑P‑CARDIA Chapter 2 data in HFpEF at ACC26 - Traders Union

Mar 28, 2026

Mar 27, 2026

Lexicon Pharmaceuticals Stock: Pipeline Progress and Financial Strategy in Biopharma Sector - AD HOC NEWS

Mar 27, 2026

Mar 26, 2026

ACC meeting features Lexicon Pharmaceuticals clinical research presentations - Traders Union

Mar 26, 2026

Mar 24, 2026

LXRX Stock Up as NVO Initiates Phase I Study of Partnered Obesity Drug - Yahoo Finance

Mar 24, 2026

Mar 24, 2026

Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo - Bitget

Mar 24, 2026

Mar 24, 2026

Lexicon brings ACC data showing heart benefits across BMI groups - Stock Titan

Mar 24, 2026

Mar 23, 2026

Lexicon Pharmaceuticals (LXRX) Receives Reiterated Buy Rating at $6.00 | LXRX Stock News - GuruFocus

Mar 23, 2026

Mar 23, 2026

Lexicon Pharmaceuticals' (LXRX) Buy Rating Reaffirmed at HC Wainwright - marketbeat.com

Mar 23, 2026

Mar 23, 2026

Novo Nordisk Begins Study of Lexicon Oral Obesity Drug - wsj.com

Mar 23, 2026

Mar 23, 2026

Lexicon Pharmaceuticals And Novo Nordisk Announce Initiation Of Phase 1 Study With Oral Obesity Drug Candidate LX9851 - TradingView

Mar 23, 2026

Mar 23, 2026

Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851 - Yahoo Finance

Mar 23, 2026

Mar 22, 2026

HC Wainwright remains a buy on Lexicon Pharmaceuticals (LXRX) - MSN

Mar 22, 2026

Mar 22, 2026

Published on: 2026-03-22 17:56:17 - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

LXRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 21, 2026

Mar 20, 2026

H.C. Wainwright Remains a Buy on Lexicon Pharmaceuticals (LXRX) - Insider Monkey

Mar 20, 2026

Mar 19, 2026

Lexicon Pharmaceuticals advances chronic pain treatment options with focus on non opioid innovation - Traders Union

Mar 19, 2026

Mar 18, 2026

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2025 Earnings Call Transcript - MSN

Mar 18, 2026

Mar 18, 2026

Lexicon Pharma spikes after insider buy - MSN

Mar 18, 2026

Mar 18, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Mar 18, 2026

Mar 18, 2026

Growth Value: How does Lexicon Pharmaceuticals Inc compare to its peers2026 EndofMonth & Low Drawdown Investment Ideas - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Dip Buying: How much upside does Lexicon Pharmaceuticals Inc have2026 PreEarnings & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Mar 17, 2026

Mar 17, 2026

HC Wainwright raises its price target on Lexicon Pharmaceuticals, Inc. (LXRX) to $6 from $4 and maintains a buy rating - MSN

Mar 17, 2026

Mar 17, 2026

Lexicon Pharmaceuticals, Inc.Common Stock (NQ: LXRX - The Chronicle-Journal

Mar 17, 2026

Mar 16, 2026

Lexicon Pharmaceuticals (LXRX) 2025 10-K: pipeline updates, collaborations - Stock Titan

Mar 16, 2026

Mar 16, 2026

Lexicon Pharmaceuticals (NASDAQ: LXRX) asks holders to double shares, renew equity plans - Stock Titan

Mar 16, 2026

Mar 13, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rapid Micro Biosystems (RPID), Lexicon Pharmaceuticals (LXRX) and Whitehawk Therapeutics (WHWK) - The Globe and Mail

Mar 13, 2026

Mar 12, 2026

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2025 earnings call transcript - MSN

Mar 12, 2026

Mar 12, 2026

H.C. Wainwright reiterates Buy on Lexicon Pharmaceuticals stock By Investing.com - Investing.com Canada

Mar 12, 2026

Mar 12, 2026

H.C. Wainwright Raises its Price Target on Lexicon Pharmaceuticals, Inc. (LXRX) to $6 from $4 and Maintains a Buy Rating - Insider Monkey

Mar 12, 2026

Mar 11, 2026

Lexicon Pharmaceuticals at Leerink Conference: Strategic Pipeline Focus By Investing.com - Investing.com Canada

Mar 11, 2026

Mar 11, 2026

LXRX: Late-stage trials and regulatory milestones drive pipeline progress and strategic partnerships - TradingView

Mar 11, 2026

Mar 11, 2026

Lexicon Pharmaceuticals (LXRX) to Present Key Findings on Sotagl - GuruFocus

Mar 11, 2026

Mar 11, 2026

Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes - The Manila Times

Mar 11, 2026

Mar 11, 2026

Diabetes drug sotagliflozin cut low-sugar events, across kidney stages - Stock Titan

Mar 11, 2026

Mar 10, 2026

Citigroup Raises Price Target for Lexicon Pharmaceuticals (LXRX) - GuruFocus

Mar 10, 2026

Mar 10, 2026

Citigroup Forecasts Strong Price Appreciation for Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock - MarketBeat

Mar 10, 2026

Mar 09, 2026

Lexicon Pharmaceuticals Signals Leaner Path to Key Milestones - TipRanks

Mar 09, 2026

Mar 09, 2026

What is HC Wainwright's Estimate for LXRX Q1 Earnings? - MarketBeat

Mar 09, 2026